Trial Profile

LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Betamethasone-dipropionate/calcipotriol (Primary)
Indications Plaque psoriasis
Focus Registrational; Therapeutic Use
Acronyms PSO-ABLE
Sponsors LEO Pharma

Most Recent Events

19 Nov 2020 Results of cost analysis assessing cost per responder, presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
28 Jun 2018 Results published in the European Journal of Dermatology
19 Jul 2017 Results of post hoc analysis (n=50) published in the British Journal of Dermatology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com